| 1 |
Combined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspectiveCombined hepatocellular-cholangiocarcinoma: a contemporary pathologic and molecular perspective
Taek ChungTaek Chung
KMSID: 1516095406 J Liver Cancer. 2026;26(1):1-8. Published online 2026 March 9 DOI: http://dx.doi.org/10.17998/jlc.2026.03.06 |
|
| 9 |
Imaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advancesImaging differentiation of hepatocellular carcinoma, combined hepatocellular-cholangiocarcinoma, and intrahepatic cholangiocarcinoma: pitfalls and advances
Jaeseung Shin, Taek Chung, Sang Yun Ha, Hyungjin RheeJaeseung Shin, Taek Chung, Sang Yun Ha, Hyungjin Rhee
KMSID: 1516095405 J Liver Cancer. 2026;26(1):9-18. Published online 2026 March 5 DOI: http://dx.doi.org/10.17998/jlc.2026.03.05 |
|
| 19 |
Surgical management of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a narrative review of principles, technical nuances, and emerging strategiesSurgical management of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a narrative review of principles, technical nuances, and emerging strategies
Woohyung Lee, Kwang Pyo Hong, Jae Hoon Lee, Mirang Lee, Minkyu Sung, Seung Jae Lee, Ki Byung Song, Dae Wook Hwang, Song Cheol KimWoohyung Lee, Kwang Pyo Hong, Jae Hoon Lee, Mirang Lee, Minkyu Sung, Seung Jae Lee, Ki Byung Song, Dae Wook Hwang, Song Cheol Kim
KMSID: 1516095400 J Liver Cancer. 2026;26(1):19-28. Published online 2026 February 5 DOI: http://dx.doi.org/10.17998/jlc.2026.01.24 |
|
| 29 |
Contemporary overview of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinomaContemporary overview of liver transplantation for intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
Hae Won LeeHae Won Lee
KMSID: 1516095404 J Liver Cancer. 2026;26(1):29-35. Published online 2026 March 5 DOI: http://dx.doi.org/10.17998/jlc.2026.03.03 |
|
| 36 |
Systemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapySystemic therapy for combined hepatocellular-cholangiocarcinoma: a comprehensive review of chemotherapy, immunotherapy, and targeted therapy
Jung Yong Hong, Dong Hyun Sinn, Sang Yun HaJung Yong Hong, Dong Hyun Sinn, Sang Yun Ha
KMSID: 1516095402 J Liver Cancer. 2026;26(1):36-44. Published online 2026 March 5 DOI: http://dx.doi.org/10.17998/jlc.2026.03.02 |
|
| 45 |
Systemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future directionSystemic treatment strategies for combined hepatocellular-cholangiocarcinoma: current evidence and future direction
Jeesun YoonJeesun Yoon
KMSID: 1516095399 J Liver Cancer. 2026;26(1):45-54. Published online 2026 February 26 DOI: http://dx.doi.org/10.17998/jlc.2026.02.24 |
|
| 55 |
The role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectivesThe role of radiotherapy in the management of combined hepatocellular-cholangiocarcinoma: current evidence and future perspectives
Seo Hee Choi, Woong Sub Koom, Ik Jae LeeSeo Hee Choi, Woong Sub Koom, Ik Jae Lee
KMSID: 1516095403 J Liver Cancer. 2026;26(1):55-64. Published online 2026 March 5 DOI: http://dx.doi.org/10.17998/jlc.2026.03.04 |
|
| 65 |
Immune-related adverse events in hepatocellular carcinoma: organ-specific patterns and management approachesImmune-related adverse events in hepatocellular carcinoma: organ-specific patterns and management approaches
Sul Ki Choi, Seonjeong Woo, Hong Jae ChonSul Ki Choi, Seonjeong Woo, Hong Jae Chon
KMSID: 1516095401 J Liver Cancer. 2026;26(1):65-82. Published online 2025 December 29 DOI: http://dx.doi.org/10.17998/jlc.2025.12.21 |
|
| 83 |
Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinibStrategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib
Hideki Iwamoto, Shigeo Shimose, Hironori Koga, Takumi KawaguchiHideki Iwamoto, Shigeo Shimose, Hironori Koga, Takumi Kawaguchi
KMSID: 1516095397 J Liver Cancer. 2026;26(1):83-92. Published online 2025 December 27 DOI: http://dx.doi.org/10.17998/jlc.2025.12.12 |
|
| 93 |
Re-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerationsRe-evaluating DAA therapy in active hepatocellular carcinoma: from controversy to clinical considerations
So Hyun Jeon, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok KimSo Hyun Jeon, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
KMSID: 1516095394 J Liver Cancer. 2026;26(1):93-103. Published online 2025 December 2 DOI: http://dx.doi.org/10.17998/jlc.2025.11.17 |
|
| 104 |
Exploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinomaExploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinoma
Charmi Jyotishi, Suresh Prajapati, Mansi Patel, Reeshu GuptaCharmi Jyotishi, Suresh Prajapati, Mansi Patel, Reeshu Gupta
KMSID: 1516095395 J Liver Cancer. 2026;26(1):104-123. Published online 2025 December 17 DOI: http://dx.doi.org/10.17998/jlc.2025.11.29 |
|
| 124 |
Systematic review of metabolomic profiles linked to liver cancerSystematic review of metabolomic profiles linked to liver cancer
Bao Le Thai Tran, Ngoc Hong Cao, Tung HoangBao Le Thai Tran, Ngoc Hong Cao, Tung Hoang
KMSID: 1516095393 J Liver Cancer. 2026;26(1):124-146. Published online 2025 December 2 DOI: http://dx.doi.org/10.17998/jlc.2025.10.27 |
|
| 147 |
PNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patientsPNPLA3 I148M is unrelated to HCC occurrence but associates with poorer tumor differentiation in Korean MASLD: a prospective cohort of 562 patients
Jaejun Lee, Dong Yeop Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Pil Soo SungJaejun Lee, Dong Yeop Lee, Jung Hoon Cha, Hee Sun Cho, Keungmo Yang, Hyun Yang, Mi Young Byun, Seok Keun Cho, Seong Wook Yang, Si Hyun Bae, Pil Soo Sung
KMSID: 1516095392 J Liver Cancer. 2026;26(1):147-156. Published online 2025 December 4 DOI: http://dx.doi.org/10.17998/jlc.2025.11.16 |
|
| 157 |
Liver resection versus radiofrequency ablation or transarterial chemoembolization for early multinodular BCLC-A hepatocellular carcinoma: a systematic review and meta-analysisLiver resection versus radiofrequency ablation or transarterial chemoembolization for early multinodular BCLC-A hepatocellular carcinoma: a systematic review and meta-analysis
Maria F. F. Viana, Arthur A. Braga, Lucas B. Carvalho, Danilo C. M. S. Vasconcellos, Bianca C. M. R. Alexandrino, Felipe J. F. CoimbraMaria F. F. Viana, Arthur A. Braga, Lucas B. Carvalho, Danilo C. M. S. Vasconcellos, Bianca C. M. R. Alexandrino, Felipe J. F. Coimbra
KMSID: 1516095398 J Liver Cancer. 2026;26(1):157-168. Published online 2026 February 26 DOI: http://dx.doi.org/10.17998/jlc.2026.02.21 |
|
| 169 |
A rare case of IgG4-related sclerosing cholangitis followed by rapid subsequent diagnosis of cholangiocarcinomaA rare case of IgG4-related sclerosing cholangitis followed by rapid subsequent diagnosis of cholangiocarcinoma
Gordon Hong, Amber Hussain, Eduardo Thadeu de Oliveira Correia, Akram Shalaby, Leonardo K. Bittencourt, Amit Mahipal, Lee M. Ocuin, Seth N. SclairGordon Hong, Amber Hussain, Eduardo Thadeu de Oliveira Correia, Akram Shalaby, Leonardo K. Bittencourt, Amit Mahipal, Lee M. Ocuin, Seth N. Sclair
KMSID: 1516095396 J Liver Cancer. 2026;26(1):169-175. Published online 2025 December 17 DOI: http://dx.doi.org/10.17998/jlc.2025.12.09 |
|
| 176 |
Alcohol-related hepatocellular carcinoma: surveillance and primary preventionAlcohol-related hepatocellular carcinoma: surveillance and primary prevention
Gianni TestinoGianni Testino
KMSID: 1516095391 J Liver Cancer. 2026;26(1):176-177. Published online 2026 March 5 DOI: http://dx.doi.org/10.17998/jlc.2025.09.16 |
|
